The present invention relates to use of a transglutaminase in the preparation of a medicament for inhibiting angiogenesis. Preferably, the transglutaminase is a human tissue transglutaminase. Advantageously, the medicament is for treating cancer, rheumatoid arthritis, retinopathy and/or psoriasis. Additionally, the invention relates to compositions comprising a transglutaminase in an amount sufficient to inhibit angiogenesis.

 
Web www.patentalert.com

< Drug-polymer coated stent

< Human protein kinases and uses therefor

> Kallikrein-inhibitor therapies

> Methods and compositions for inhibiting apoptosis using serine protease inhibitors
~ 00602